In ESCC, genetic alterations including Fbxo4 loss and hyperactivation of cyclin D1-CDK4/6 kinases have been frequently observed, leading to glutamine addiction (Qie et al., 2019). Here, FBXO4 is linked to esophageal squamous cell carcinoma.